Filtros de búsqueda

Lista de obras de Jonathan A Ledermann

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer ⬇️

artículo científico publicado en 2018

First-line treatment of ovarian cancer: questions and controversies to address.

artículo científico publicado en 2018

Homologous recombination deficiency and ovarian cancer.

artículo científico publicado en 2016

ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemo

artículo científico publicado en 2020

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.

artículo científico publicado en 2019

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease

artículo científico publicado en 2016

Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective review.

artículo científico publicado en 2016

Targeted Therapies for Ovarian Cancer.

artículo científico publicado en 2016

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda